These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9531033)

  • 1. Platelet cNOS activity is reduced in patients with IDDM and NIDDM.
    Martina V; Bruno GA; Trucco F; Zumpano E; Tagliabue M; Di Bisceglie C; Pescarmona G
    Thromb Haemost; 1998 Mar; 79(3):520-2. PubMed ID: 9531033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate.
    van Etten RW; de Koning EJ; Verhaar MC; Gaillard CA; Rabelink TJ
    Diabetologia; 2002 Jul; 45(7):1004-10. PubMed ID: 12136399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial nitric oxide in diabetes mellitus: too much or not enough?
    Farkas K; Sármán B; Jermendy G; Somogyi A
    Diabetes Nutr Metab; 2000 Oct; 13(5):287-97. PubMed ID: 11105972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for iNOS-dependent peroxynitrite production in diabetic platelets.
    Tannous M; Rabini RA; Vignini A; Moretti N; Fumelli P; Zielinski B; Mazzanti L; Mutus B
    Diabetologia; 1999 May; 42(5):539-44. PubMed ID: 10333045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Panminerva Med; 1998 Dec; 40(4):304-8. PubMed ID: 9973826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased superoxide production in hypertensive patients with diabetes mellitus: role of nitric oxide synthase.
    Dixon LJ; Hughes SM; Rooney K; Madden A; Devine A; Leahey W; Henry W; Johnston GD; McVeigh GE
    Am J Hypertens; 2005 Jun; 18(6):839-43. PubMed ID: 15925745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Minerva Endocrinol; 1999; 24(3-4):117-21. PubMed ID: 10953727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of glutathione in patients with type 2 diabetes mellitus increases the platelet constitutive nitric oxide synthase activity and reduces PAI-1.
    Martina V; Bruno GA; Zumpano E; Origlia C; Quaranta L; Pescarmona GP
    J Endocrinol Invest; 2001 Jan; 24(1):37-41. PubMed ID: 11227730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine-induced inhibition of nitric oxide production in platelets: a study on healthy and diabetic subjects.
    Mutus B; Rabini RA; Staffolani R; Ricciotti R; Fumelli P; Moretti N; Martarelli D; Mazzanti L
    Diabetologia; 2001 Aug; 44(8):979-82. PubMed ID: 11484074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet nitric oxide production and IR: relation with obesity and hypertriglyceridemia.
    Vignini A; Nanetti L; Moroni C; Testa R; Sirolla C; Marra M; Cenerelli S; Gregori A; Fumelli D; Olivieri F; Mazzanti L; Rabini RA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):553-8. PubMed ID: 18155481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pravastatin activates platelet nitric oxide synthase (NOS) in patients with type 2 diabetes mellitus and NOS activation is accompanied by serine phosphorylation.
    Yao K; Xu B; Gao L; Ge JB
    Chin Med J (Engl); 2005 Oct; 118(19):1654-7. PubMed ID: 16232352
    [No Abstract]   [Full Text] [Related]  

  • 12. Involvement of endothelial nitric oxide synthase in the impaired endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolemic rabbit.
    Seo KK; Yun HY; Kim H; Kim SC
    J Androl; 1999; 20(2):298-306. PubMed ID: 10232665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder.
    Chrapko WE; Jurasz P; Radomski MW; Lara N; Archer SL; Le Mellédo JM
    Biol Psychiatry; 2004 Jul; 56(2):129-34. PubMed ID: 15231445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional consequences of endothelial nitric oxide synthase uncoupling in congestive cardiac failure.
    Dixon LJ; Morgan DR; Hughes SM; McGrath LT; El-Sherbeeny NA; Plumb RD; Devine A; Leahey W; Johnston GD; McVeigh GE
    Circulation; 2003 Apr; 107(13):1725-8. PubMed ID: 12665482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet sarcoplasmic endoplasmic reticulum Ca2+-ATPase and mu-calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone.
    Randriamboavonjy V; Pistrosch F; Bölck B; Schwinger RH; Dixit M; Badenhoop K; Cohen RA; Busse R; Fleming I
    Circulation; 2008 Jan; 117(1):52-60. PubMed ID: 18071073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of long-term smoking on endothelial nitric oxide synthase mRNA expression in human platelets as detected with real-time quantitative RT-PCR.
    Shimasaki Y; Saito Y; Yoshimura M; Kamitani S; Miyamoto Y; Masuda I; Nakayama M; Mizuno Y; Ogawa H; Yasue H; Nakao K
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):43-51. PubMed ID: 17164495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on the action of vitamin E supplementation on plasminogen activator inhibitor type 1 and platelet nitric oxide production in type 2 diabetic patients.
    Vignini A; Nanetti L; Moroni C; Testa R; Sirolla C; Marra M; Manfrini S; Fumelli D; Marcheselli F; Mazzanti L; Rabini RA
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):15-22. PubMed ID: 17949955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal oestradiol replacement therapy enhances platelet constitutive nitric oxide synthase activity in postmenopausal women with type 2 diabetes mellitus.
    Martina V; Bruno GA; Origlia C; Gaia D; Trucco F; Pescarmona G
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):371-5. PubMed ID: 12201830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired activity of serum alpha-1-antitrypsin in diabetes mellitus.
    Hashemi M; Naderi M; Rashidi H; Ghavami S
    Diabetes Res Clin Pract; 2007 Feb; 75(2):246-8. PubMed ID: 16875754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.